Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01099 SINOPHARM
RTNominal down20.050 -0.350 (-1.716%)
Research Report

27/08/2019 17:23

{I-bank focus}Citi lowers Sinopharm Group (01099) to HK$38

[ET Net News Agency, 27 August 2019] Citi Research lowered its target price for
Sinopharm Group (01099) to HK$38 from HK$47 and maintained its "buy" rating.
The research house said Sinopharm's GM slightly dropped 18bps to 8.7% mainly impacted by
fast-growing proprietary pharmacies with lower margin. Operating cash flow (OCF) recorded
Rmb11bn outflow due to extended hospital payment collection. Management was confident in
achieving positive full-year OCF in 2019.
Citi adjusted the revenue, financial cost and MI (minority interest) percentage upward
in 2019/20/21 to reflect the latest business trend. (KL)

Remark: Real time quote last updated: 28/03/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.